I’m excited to present our most recent publication estimating the cost-effectiveness of future ETEC and shigella vaccines in low- and low-middle income countries. This novel work, published in Vaccine X, builds on our previous estimates of the burden of ETEC and shigella infections and stunting in children. We attempt to capture the heterogeneity in burden and access in different regions and countries that leads to a wide range of anticipated impact and cost-effectiveness. This information is useful for policy makers in considering the introduction of future vaccines. Both articles are open access and can be downloaded for free.
Category Archives: ETEC
New Research Published: Burden of enterotoxigenic Escherichia coli and shigella non-fatal diarrhoeal infections in 79 low-income and lower middle-income countries: a modelling analysis
I am proud to announce that our research on the global burden of diarrhea and stunting caused by childhood ETEC and shigella infections in 79 low and low-middle income countries has been published in the latest issue of the Lancet Global Health! We applied a novel approach to capture the additional burden of other infectious diseases caused by stunting attributed to non-fatal ETEC and shigella diarrheal episodes during childhood. This method allows us to better understand the total burden of disease caused by these major enteric pathogens.
Special thanks to all of my colleagues for their contributions on this research over the past couple of years! Our publication is open source and free to download.
John D. Anderson IV 